{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:22:31Z","timestamp":1789593751283,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.humpath.2026.106077","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T16:14:21Z","timestamp":1771431261000},"page":"106077","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Navigating diagnostic shifts: A comparative review of the WHO 5th edition and ICC 2022 classifications of myeloid neoplasms"],"prefix":"10.1016","volume":"169","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9275-6056","authenticated-orcid":false,"given":"Sharon","family":"Koorse Germans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga K.","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.humpath.2026.106077_bib1","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/Dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.humpath.2026.106077_bib2","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International consensus classification of myeloid neoplasms and acute leukemias: integrating morphology, genomics, and clinical features","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.humpath.2026.106077_bib3","first-page":"25","article-title":"Reclassification of myelodysplastic syndromes according to WHO 2022 and ICC 2022: a real-world cohort study","volume":"14","author":"Lee","year":"2024","journal-title":"Blood Cancer J"},{"issue":"10","key":"10.1016\/j.humpath.2026.106077_bib4","first-page":"1045","article-title":"Accelerated phase and blast phase in CML and related disorders","volume":"142","author":"Valent","year":"2023","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.humpath.2026.106077_bib5","first-page":"420","article-title":"Outcome-driven classification of MDS\/MPN overlap neoplasms","volume":"143","author":"Cargo","year":"2024","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.humpath.2026.106077_bib6","first-page":"150","article-title":"Impact of WHO 2022 and ICC classifications on AML risk stratification","volume":"38","author":"Nachtkamp","year":"2024","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.humpath.2026.106077_bib7","first-page":"456","article-title":"Clinical implications of reclassification of acute myeloid leukemia under WHO 2022 and ICC","volume":"99","author":"Moore","year":"2024","journal-title":"Am J Hematol"},{"issue":"5","key":"10.1016\/j.humpath.2026.106077_bib8","first-page":"1234","article-title":"Prognostic impact of TP53 mutations in AML with myelodysplasia-related changes","volume":"8","author":"Zhou","year":"2024","journal-title":"Blood Adv"},{"issue":"12","key":"10.1016\/j.humpath.2026.106077_bib9","first-page":"2345","article-title":"Therapy-related myeloid neoplasms revisited","volume":"7","author":"Attardi","year":"2023","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.humpath.2026.106077_bib10","first-page":"455","article-title":"Harmonization of myeloid neoplasm classification systems","volume":"38","author":"Cargo","year":"2024","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.humpath.2026.106077_bib11","first-page":"2335","article-title":"Diagnostic reproducibility in myeloid neoplasms","volume":"108","author":"Germing","year":"2023","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.humpath.2026.106077_bib12","first-page":"889","article-title":"Proposed diagnostic criteria for myelodysplastic\/myeloproliferative neoplasms","volume":"37","author":"Valent","year":"2023","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.humpath.2026.106077_bib13","first-page":"745","article-title":"Clonal cytopenia and clonal hematopoiesis: WHO and ICC perspectives","volume":"142","author":"Valent","year":"2023","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.humpath.2026.106077_bib14","first-page":"913","article-title":"Clinical significance of somatic mutation patterns in myelodysplastic syndromes","volume":"141","author":"Malcovati","year":"2023","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.humpath.2026.106077_bib15","first-page":"720","article-title":"Revised IPSS-molecular risk stratification","volume":"141","author":"Greenberg","year":"2023","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.humpath.2026.106077_bib16","first-page":"345","article-title":"Myeloproliferative neoplasms: WHO and ICC updates","volume":"142","author":"Tefferi","year":"2023","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.humpath.2026.106077_bib17","first-page":"1356","article-title":"MDS\/MPN with ring sideroblasts and thrombocytosis revisited","volume":"98","author":"Patnaik","year":"2023","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.humpath.2026.106077_bib18","first-page":"201","article-title":"Polycythemia vera and essential thrombocythemia: molecular classification","volume":"141","author":"Vannucchi","year":"2023","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.humpath.2026.106077_bib19","first-page":"1231","article-title":"Bone marrow morphology in MPN classification","volume":"108","author":"Thiele","year":"2023","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.humpath.2026.106077_bib20","first-page":"289","article-title":"Chronic neutrophilic leukemia and atypical CML","volume":"142","author":"Valent","year":"2023","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.humpath.2026.106077_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3343\/alm.2017.37.1.1","article-title":"Comparative analysis of WHO-HAEM5 and ICC classifications in myeloid neoplasms","volume":"45","author":"Yun","year":"2025","journal-title":"Ann Lab Med"},{"issue":"1","key":"10.1016\/j.humpath.2026.106077_bib22","first-page":"1","article-title":"Essential thrombocythemia and prefibrotic myelofibrosis: diagnostic boundaries","volume":"37","author":"Barbui","year":"2023","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.humpath.2026.106077_bib23","first-page":"345","article-title":"Molecular genetics of CMML and MDS\/MPN overlap neoplasms","volume":"204","author":"Cargo","year":"2024","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2026.106077_bib24","first-page":"85","article-title":"Chronic myelomonocytic leukemia: contemporary review","volume":"13","author":"Patnaik","year":"2023","journal-title":"Blood Cancer J"},{"issue":"9","key":"10.1016\/j.humpath.2026.106077_bib25","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/modpathol.2017.45","article-title":"Oligomonocytic CMML displays a similar clinicopathologic and mutational profile to classical CMML","volume":"30","author":"Geyer","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2026.106077_bib26","article-title":"Definitions and standards in the diagnosis of MDS\/MPN","volume":"128","author":"Valent","year":"2023","journal-title":"Leuk Res"},{"issue":"9","key":"10.1016\/j.humpath.2026.106077_bib27","first-page":"1037","article-title":"Juvenile myelomonocytic leukemia: biology and classification","volume":"141","author":"Niemeyer","year":"2023","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.humpath.2026.106077_bib28","first-page":"210","article-title":"Genomic and epigenomic landscape of JMML","volume":"56","author":"Stieglitz","year":"2024","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.humpath.2026.106077_bib29","first-page":"789","article-title":"Reclassification of TP53-mutated myeloid neoplasms under WHO-HAEM5 and ICC systems","volume":"99","author":"Chen","year":"2024","journal-title":"Am J Hematol"},{"key":"10.1016\/j.humpath.2026.106077_bib30","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41408-025-01290-0","article-title":"Validation of the 5th edition of the World Health Organization and International Consensus Classification guidelines for TP53-mutated myeloid neoplasm in an independent international cohort","volume":"15","author":"Shah","year":"2025","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.humpath.2026.106077_bib31","first-page":"1234","article-title":"DNA methylation profiling stratifies JMML","volume":"14","author":"Caye","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.humpath.2026.106077_bib32","article-title":"TP53-mutated myeloid neoplasms: biology and classification challenges","volume":"135","author":"Khanna","year":"2024","journal-title":"Leuk Res"},{"key":"10.1016\/j.humpath.2026.106077_bib33","doi-asserted-by":"crossref","first-page":"e862","DOI":"10.1016\/S2352-3026(24)00251-5","article-title":"Data-driven, harmonised classification system for myelodysplastic syndromes: a consensus paper from the International Consortium for Myelodysplastic Syndromes","volume":"11","author":"Komrokji","year":"2024","journal-title":"Lancet Haematol"},{"issue":"6","key":"10.1016\/j.humpath.2026.106077_bib34","first-page":"628","article-title":"Germline predisposition in pediatric myeloid neoplasms","volume":"141","author":"Wlodarski","year":"2023","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.humpath.2026.106077_bib35","first-page":"401","article-title":"JMML clinical trials and transplant outcomes","volume":"143","author":"Loh","year":"2024","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.humpath.2026.106077_bib36","first-page":"987","article-title":"Survival and disease progression in myeloproliferative neoplasms","volume":"37","author":"Barbui","year":"2023","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.humpath.2026.106077_bib37","first-page":"17","article-title":"Classification of myeloid neoplasms: perspectives for harmonization","volume":"21","author":"Solary","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"10.1016\/j.humpath.2026.106077_bib38","first-page":"150","article-title":"Epigenetic and targeted therapies in JMML","volume":"143","author":"Stieglitz","year":"2024","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.humpath.2026.106077_bib39","first-page":"145","article-title":"Molecular risk stratification in JMML","volume":"21","author":"Wlodarski","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"10.1016\/j.humpath.2026.106077_bib40","first-page":"281","article-title":"Molecular landscape of myeloid neoplasms","volume":"37","author":"Haferlach","year":"2023","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.humpath.2026.106077_bib41","first-page":"345","article-title":"Interobserver variability in blast assessment in myelodysplastic neoplasms","volume":"14","author":"Vicente","year":"2024","journal-title":"Diagnostics"},{"issue":"6","key":"10.1016\/j.humpath.2026.106077_bib42","first-page":"590","article-title":"Diagnosis and management of AML in the era of molecular classification","volume":"141","author":"D\u00f6hner","year":"2023","journal-title":"Blood"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817726000468?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817726000468?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T15:36:09Z","timestamp":1772724969000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817726000468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":42,"alternative-id":["S0046817726000468"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106077","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Navigating diagnostic shifts: A comparative review of the WHO 5th edition and ICC 2022 classifications of myeloid neoplasms","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106077"}}